Results 211 to 220 of about 915,020 (267)

Drug Release

2021
Fil: Ruiz, María Esperanza. Universidad Nacional de La Plata. Facultad de Ciencas Exactas. Laboratorio de Investigación y Desarrollo de Bioactivos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas.
Talevi, Alan, Ruiz, María Esperanza
openaire   +2 more sources

Nitric Oxide–Releasing Drugs

Annual Review of Pharmacology and Toxicology, 2003
Pharmacological compounds that release nitric oxide (NO) have been useful tools for evaluating the broad role of NO in physiology and therapeutics. NO deficiency has been implicated in the genesis and evolution of several disease states. Both medical needs and commercial opportunities have fostered attempts to modulate NO in the human body for ...
Claudio, Napoli, Louis J, Ignarro
openaire   +2 more sources

Drug Release from Suppositories

Pharmaceutical Research, 1985
Many studies have been carried out over the past decades on suppositories and their drug release properties. The present state of knowledge is reviewed with the conclusion that our current understanding of the in vivo performance of suppositories is deficient.
C J, de Blaey, J G, Fokkens
openaire   +2 more sources

Modeling transdermal drug release

Advanced Drug Delivery Reviews, 2001
The stratum corneum forms the outermost layer of the skin and is essentially a multilamellar lipid milieu punctuated by protein-filled corneocytes that augment membrane integrity and significantly increase membrane tortuosity. The lipophilic character of the stratum corneum, coupled with its intrinsic tortuosity, ensure that it almost always provides ...
Kalia, Yogeshvar, Guy, Richard H.
openaire   +3 more sources

Antipsychotic drugs stimulate prolactin release

Psychopharmacologia, 1974
Antipsychotic drugs have been found to markedly stimulate prolactin secretion in male and female rats. The amount of prolactin released was greater in females than in males. Most non-antipsychotic phenothiazines failed to alter prolactin. These results imply that the dopamine receptor that inhibits prolactin release may be similar to the dopamine ...
J A, Clemens, E B, Smalstig, B D, Sawyer
openaire   +2 more sources

Pectin as Drug-Release Vehicle

2020
Pectin as a natural biopolymer is extensively used for pharmaceutical and biomedical applications, essentially due to its gelling properties that could be influenced by pectin sources and extraction methods. This chapter focuses on an overview of pectin drug delivery systems classified by their administration routes.
Assifaoui, Ali, Chambin, Odile
openaire   +3 more sources

Beta-Glucuronidase-Mediated Drug Release

Current Pharmaceutical Design, 2002
The selective activation of a relatively non-toxic prodrug by an enzyme present only in the tumour should enhance the drug concentration at the tumour site and result in a better anti-tumour effect and a reduction in systemic toxicity as compared to conventional chemotherapy. beta-Glucuronidase is such an enzyme.
Michelle, de Graaf   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy